Moderna Inc on Tuesday sought conditional advertising authorization from the European Medicines Agency for using the Kovid-19 vaccine in youngsters aged 6-11 years.
The vaccine was approved by the European Union in July to be used in adolescents aged 12 to 17 years, however a number of nations, together with Sweden, have restricted its use to these 30 years and youthful due to uncommon heart-related unwanted effects. has stopped.
The drugmaker sought US authorization for its vaccine to be used in teenagers in June and is awaiting a choice from the US Food and Drug Administration.
“This is our first submission to our vaccine use in this age group,” mentioned Moderna’s chief govt officer, Stephen Bunsell. Adding the corporate will permit information to be submitted to different regulatory companies all over the world.
.
With inputs from TheIndianEXPRESS
